KFC
AGN

Klingenstein Fields & Co’s Allergan Inc AGN Stock Holding History

Klingenstein Fields & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,000
Closed -$638K – 255
2014
Q4 		$638K Sell
3,000
-100
-3% -$19.9K 0.03% 139
2014
Q3 		$552K Buy
3,100
+100
+3% +$16.6K 0.02% 153
2014
Q2 		$508K Hold
3,000
– – 0.02% 168
2014
Q1 		$372K Sell
3,000
-1,500
-33% -$183K 0.02% 187
2013
Q4 		$500K Buy
4,500
+856
+23% +$81.8K 0.02% 207
2013
Q3 		$330K Sell
3,644
-3,420
-48% -$307K 0.01% 243
2013
Q2 		$595K Buy
+7,064
New +$733K 0.02% 195

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Klingenstein Fields & Co's AGN Position: Q1 2015 in Review

Klingenstein Fields & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 3,000 shares — an estimated $638K sold.

Klingenstein Fields & Co first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $638K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Klingenstein Fields & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Klingenstein Fields & Co sold 3,000 Allergan Inc shares in Q1 2015, an estimated $638K.
  • Klingenstein Fields & Co first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Klingenstein Fields & Co's Allergan Inc position peaked at $638K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Klingenstein Fields & Co's 13F filing for Q1 2015, filed 5 May 2015.